BIO Medica Laboratories L
NSE: BMLL · Other · sector
₹146.40NSE close 2026-10-26
Key numbers
Market cap₹134 cr
Price₹146.40
52w high / low₹181 / ₹102
P/E11.3xSector median 14.4x
P/B7.8xSector median 1.7x
Book value₹18.9
Dividend yield–Sector median 0.37%
ROE68.0%Sector median 13.8%
ROCE106.8%Sector median 19.6%
OPM45.6%Sector median 10.4%
Debt / equity–Sector median 0.29x
EV/EBITDA6.8xSector median 8.4x
Interest cover8.2x
Current ratio2.85x
Sales growth 3y–Sector median +7.7%
Profit growth 3y–Sector median +16.6%
PEG–
Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 8.2x in the last 12 months.
- Other income was 0% of net profit in the last 12 months.
- No dividend in the last 1 financial years.
- Price ₹146.40 on 2026-10-26: -19.1% from the 52-week high, +44.2% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹168.50 · low ₹106.15
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2026 |
|---|---|
| Revenue | 43 |
| EBITDA | 20 |
| OPM % | 45.6% |
| Other income | 0 |
| Net profit | 12 |
| EPS (₹) | 12.95 |
Consolidated figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY26 | TTM |
|---|---|---|
| Revenue | 43 | 43 |
| EBITDA | 20 | 20 |
| Net profit | 12 | 12 |
| EPS (₹) | 12.95 | 12.95 |
| Dividend / share (₹) | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | – |
Balance sheet
| ₹ cr | FY26 |
|---|---|
| Shareholders' equity | 17 |
| Cash & equivalents | 0 |
| Total assets | 73 |
| Fixed assets | 10 |
| Investments | 0 |
| Inventory | 36 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY26 |
|---|---|
| Cash from operations | -6 |
| Cash from investing | -2 |
| Cash from financing | 8 |
| Capex | 3 |
| Free cash flow | -9 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY26 |
|---|---|
| ROE % | 68.0% |
| ROCE % | 106.8% |
| Inventory days | 759 |
| Working capital days | 301 |
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| BMLL | ₹134 cr | 11.3x | 7.8x | 68.0% | 106.8% | 45.6% | – | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | BMLL |
| BSE code | – |
| ISIN | INE1BKA01015 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.